Breaking News

Conducting Clinical Trials Amid COVID-19

Medable releases global TeleVisit capabilities to enable continued clinical trial research in light of growing COVID-19 concerns

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

In response to the global COVID-19 pandemic, Medable has developed a new TeleVisit mobile application that can be used by patients worldwide to connect virtually with their clinical trial sites. The application makes it possible for clinical trial research to progress in an environment where many patients are being told to stay home and avoid social interaction. The application includes the following capabilities:   • Consents patients in their native language for the use of telemedicine; • Prov...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters